Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel

Bibliography

• Feng SS, Chien S. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem Eng Sci 2003;58(18):4087-114
   Web of Science ®Google Scholar
• Muthu MS, Feng SS. Nanopharmacology of liposomes developed for cancer therapy. Nanomedicine (Lond) 2010;5:1017-19
   PubMed Web of Science ®Google Scholar
• Sharma G, Anabousi S, Ehrhardt C, Ravi Kumar MNV. Liposomes as targeted drug delivery systems in the treatment of breast cancer. J Drug Target 2006;14(5):301-10
   PubMed Web of Science ®Google Scholar
• Torchilin V. Antibody-modified liposomes for cancer chemotherapy. Expert Opin Drug Deliv 2008;5(9):1003-25
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Preat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 2010;148(2):135-46
   PubMed Web of Science ®Google Scholar
• Liu Y, Li K, Liu B, Feng SS. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials 2010;31(35):9145-55
   PubMed Web of Science ®Google Scholar
• Sun BF, Feng SS. Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel. Nanomedicine 2009;4(4):431-45
   PubMed Web of Science ®Google Scholar
• Steinhauser I, Spankuch B, Strebhardt K, Langer K. Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. Biomaterials 2006;27(28):4975-83
   PubMed Web of Science ®Google Scholar
• Park JW, Hong K, Kirpotin DB, et al. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res 2002;8(4):1172-81
   PubMed Web of Science ®Google Scholar
• Kirpotin D, Park JW, Hong K, et al. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry 1997;36(1):66-75
   PubMed Web of Science ®Google Scholar
• Wu S, Hopkins W. Characteristics of D-alpha-Tocopheryl polyethylene glycol 1000 succinate for applications as an absorption enhancer in drug delivery system. Pharm Technol 1999;23:52-68
   Google Scholar
• Varma MVS, Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E–TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 2005;25:445-53
   PubMed Web of Science ®Google Scholar
• Jay M, Dintaman JAS. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate. Pharm Res 1999;16(10):7
   PubMedGoogle Scholar
• Boudreaux JP, Hayes DH, Mizrahi P, et al. Use of water-soluble liquid vitamin-E to enhance cyclosporine absorption in children after liver-transplant. Transplant Proc 1993;25:1875
   PubMed Web of Science ®Google Scholar
• Mu L, Elbayoumi TA, Torchilin VP. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 2005;306(1-2):142-9
   PubMed Web of Science ®Google Scholar
• Cao N, Feng SS. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials 2008;29(28):3856-65
   PubMed Web of Science ®Google Scholar
• Anbharasi V, Cao N, Feng SS. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy. J Biomed Mater Res A 2010;94(3):730-43
   PubMedGoogle Scholar
• Mu L, Feng SS. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm Res 2003;20:1864-72
   PubMed Web of Science ®Google Scholar
• Zhang ZP, Feng SS. The drug encapsulation efficiency, in vitro release, cellular uptake and cytotoxicity in paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 2006;27:4025-33
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for control release of paclitaxel (Taxol®). J Control Release 2002;80:129-44
   PubMed Web of Science ®Google Scholar
• Win KY, Feng SS. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials 2006;27(10):2285-91
   PubMed Web of Science ®Google Scholar
• Mi Y, Liu Y, Feng SS. Formulation of Docetaxel by folic acid-conjugated d-alpha-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Biomaterials 2011;32(16):4058-66
   PubMed Web of Science ®Google Scholar
• Wang AJ, Wang PL, Lu SJ, Industrial Technology Research Institute. Long circulating liposome, Tiwan; 2005
   Google Scholar
• Muthu MS, Kulkarni SA, Xiong J, Feng SS. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 2011;421(2):332-40
   PubMed Web of Science ®Google Scholar
• Bissery MC, Guénard D, Gueritte-Voegelein F, Lavelle F. Experimental Antitumor Activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 1991;51:4845-52
   PubMed Web of Science ®Google Scholar
• Liu J, Li J, Rosol TJ, et al. Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro. Phys Med Biol 2007;52(16):4739-47
   PubMed Web of Science ®Google Scholar
• Muthu MS, Rawat MK, Mishra A, Singh S. PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine 2009;5:323-33
   PubMed Web of Science ®Google Scholar
• Muthu MS, Singh S. Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. Nanomedicine (Lond) 2008;3:305-19
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Raju A, Feng SS. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials 2012;33(12):3494-501
   PubMed Web of Science ®Google Scholar
• Kocbek P, Obermajer N, Cegnar M, et al. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release 2007;120(1-2):18-26
   PubMed Web of Science ®Google Scholar
• Zhao L, Feng SS. Effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within the lipid monolayer at the air–water interface. J Colloid Interface Sci 2006;300:314-26
   PubMed Web of Science ®Google Scholar
• Prashant C, Dipak M, Yang CT, et al. Superparamagnetic iron oxide–loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent. Biomaterials 2010;31(21):5588-97
   PubMed Web of Science ®Google Scholar
• Arya G, Vandana M, Acharya S, Sahoo SK. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. Nanomedicine 2011;7(6):859-70
   PubMed Web of Science ®Google Scholar
• Zhao L, Feng SS, Kocherginsky N, Kostetski I. DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane. Int J Pharm 2007;338(1-2):258-66
   PubMedGoogle Scholar
• Chieng YY, Chen SB. Interaction and complexation of phospholipid vesicles and triblock copolymers. J Phys Chem B 2009;113:14934-42
   PubMed Web of Science ®Google Scholar
• Sheu MT, Chen SY, Chen LC, Ho HO. Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol. J Control Release 2003;88:355-68
   PubMed Web of Science ®Google Scholar
• Gupta Y, Jain A, Jain P, Jain SK. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells. J Drug Target 2007;15:231-40
   PubMed Web of Science ®Google Scholar
• Wu J, Liu Q, Lee RJ. A folate receptor-targeted liposomal formulation for paclitaxel. Int J Pharm 2006;316(1-2):148-53
   PubMedGoogle Scholar
• Gan CW, Feng SS. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials 2010;31(30):7748-57
   PubMed Web of Science ®Google Scholar
• Dadashzadeh S, Vali AM, Rezaie M. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats. Int J Pharm 2008;353(1-2):251-9
   PubMedGoogle Scholar
• Muthu MS, Kulkarni SA, Liu Y, Feng SS. Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine (Lond) 2012;7(3):353-64
   PubMed Web of Science ®Google Scholar
• Muthu MS, Feng SS. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success. Expert Opin Drug Deliv 2013;10(2):151-5
   PubMed Web of Science ®Google Scholar